- Investing Ideas
- /
- Pharmaceuticals & Biotech UK Established Discount
Pharmaceuticals & Biotech UK Established Discount
Results
82
0 new
Big ticket companies showing a potential underpricing based on intrinsic value
82 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EXAS | US$65.96 | -5.9% | -3.3% | US$12.6b | US$77.57 | PS4.7x | E70.9% | n/a | ||
INCY | US$65.83 | 0.1% | 14.0% | US$12.5b | US$74.17 | PE130.3x | E41.1% | n/a | ||
INSM | US$72.48 | -2.3% | 187.0% | US$12.5b | US$87.50 | PS37.9x | E53.7% | n/a | ||
SRPT | US$124.53 | -2.1% | 2.7% | US$11.9b | US$194.36 | PE251.1x | E44.1% | n/a | ||
NBIX | US$115.06 | -2.8% | 2.3% | US$11.7b | US$168.72 | PE34.3x | E29.3% | n/a | ||
MEDP | US$331.44 | -9.4% | 36.9% | US$10.1b | US$389.47 | PE30.2x | E13.5% | n/a | ||
QGEN | US$45.24 | 0.8% | 8.4% | US$10.0b | US$50.97 | PE138.3x | E37.1% | n/a | ||
ASND | US$144.62 | -4.4% | 54.4% | US$8.8b | US$193.94 | PS24.3x | E67.9% | n/a | ||
LEGN | US$49.27 | 1.5% | -26.6% | US$8.6b | US$82.98 | PS19.9x | E63.7% | n/a | ||
RGEN | US$145.93 | 2.1% | -8.2% | US$8.2b | US$193.82 | PS13.6x | E91.8% | n/a | ||
ITCI | US$73.30 | -5.6% | 40.7% | US$7.7b | US$96.13 | PS13.7x | E64.4% | n/a | ||
EXEL | US$25.96 | -1.7% | 18.8% | US$7.5b | US$27.60 | PE21.2x | E15.7% | n/a | ||
HALO | US$56.91 | -3.9% | 49.0% | US$7.2b | US$61.10 | PE21.4x | E22.0% | n/a | ||
JAZZ | US$110.93 | 0.2% | -14.3% | US$6.8b | US$178.78 | PE17.3x | E20.1% | n/a | ||
ELAN | US$14.32 | 1.8% | 27.4% | US$6.8b | US$18.63 | PS1.6x | E73.7% | n/a | ||
CYTK | US$52.34 | -2.7% | 77.7% | US$6.2b | US$81.29 | PS1965x | E43.1% | n/a | ||
BPMC | US$92.42 | 0.8% | 84.0% | US$5.6b | US$127.35 | PS16.1x | E67.4% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
RNA | US$42.17 | -7.6% | 542.8% | US$5.4b | US$66.09 | PS466x | E25.5% | n/a | ||
KRYS | US$177.14 | -3.8% | 52.7% | US$5.1b | US$207.22 | PE48x | E34.2% | n/a | ||
RARE | US$54.43 | -7.4% | 52.7% | US$5.1b | US$90.00 | PS10.4x | E50.7% | n/a | ||
OGN | US$19.18 | -1.6% | 10.5% | US$4.9b | US$22.75 | PE4.9x | E7.2% | 5.8% | ||
SHC | US$16.76 | 0.6% | 11.9% | US$4.7b | US$16.36 | PE118.9x | E48.2% | n/a | ||
MDGL | US$212.43 | -9.0% | 45.5% | US$4.6b | US$360.57 | PS315.1x | E68.1% | n/a |